Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “Myelodysplastic syndrome”
Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
ClinicalTrials.gov study NCT00397813. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03047993. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01254890. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00217594. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Extension Study to Evaluate Long-Term Effects of Luspatercept in Patients With Myelodysplastic Syndromes (MDS) (A536-05/MK-6143-003)
ClinicalTrials.gov study NCT02268383. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q
ClinicalTrials.gov study NCT01029262. IPD Sharing: Not stated. Countries: 16. Publications: 3.
Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1
ClinicalTrials.gov study NCT04874194. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00072475. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01165996. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT02228525. IPD Sharing: Not stated. Countries: 1. Publications: 1.
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03358719. IPD Sharing: Not stated. Countries: 1. Publications: 1.
RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00809185. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01546038. IPD Sharing: YES. Countries: 6. Publications: 6.
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT01522976. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02728050. IPD Sharing: NO. Countries: 1. Publications: 1.
An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00346632. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00948064. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00910858. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care
ClinicalTrials.gov study NCT00071799. IPD Sharing: Not stated. Countries: 15. Publications: 6.
Bortezomib in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00262873. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.